The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study

被引：0
|
作者：
Alessia Melegaro
Valentina Marziano
Emanuele Del Fava
Piero Poletti
Marcello Tirani
Caterina Rizzo
Stefano Merler
机构：
[1] Bocconi University,Department of Social and Political Sciences
[2] Bocconi University,Carlo F. Dondena Centre for Research on Social Dynamics and Public Policy
[3] Center for Information and Communication Technology,undefined
[4] Bruno Kessler Foundation,undefined
[5] Department of Hygiene and Preventive Medicine,undefined
[6] ATS,undefined
[7] Department of Infectious Disease,undefined
[8] Istituto Superiore di Sanità,undefined
来源：
BMC Medicine | / 16卷
关键词：
Varicella; Chickenpox; Herpes zoster; Shingles; Vaccination; Italy; Cost-effectiveness; Modelling; Individual-based models; Demography; Immunisation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Modelling varicella vaccination - What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?
    Widgren, Katarina
    Tomba, GianPaolo Scalia
    Leung, Ka Yin
    Giesecke, Johan
    VACCINE, 2022, 40 (04) : 673 - 681
  • [12] Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis
    Bresse, Xavier
    Annemans, Lieven
    Preaud, Emmanuelle
    Bloch, Karine
    Duru, Gerard
    Gauthier, Aline
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (03) : 393 - 406
  • [13] Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review
    Kawai, Kosuke
    Preaud, Emmanuelle
    Baron-Papillon, Florence
    Largeron, Nathalie
    Acosta, Camilo J.
    VACCINE, 2014, 32 (15) : 1645 - 1653
  • [14] Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales
    van Hoek, A. J.
    Gay, N.
    Melegaro, A.
    Opstelten, W.
    Edmunds, W. J.
    VACCINE, 2009, 27 (09) : 1454 - 1467
  • [15] Cost-effectiveness of varicella zoster vaccination in older adults
    Anthony M. H. Ho
    Paul Coplan
    Anna Lee
    Gavin M Joynt
    Manoj K Karmakar
    Canadian Journal of Anesthesia, 2006, 53 (Suppl 1): : 26394 - 26394
  • [16] Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands
    de Boer, Pieter T.
    Pouwels, Koen B.
    Cox, Juul M.
    Hak, Eelko
    Wilschut, Jan C.
    Postma, Maarten J.
    VACCINE, 2013, 31 (09) : 1276 - 1283
  • [17] Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness Analysis
    Phuc Le
    Rothberg, Michael B.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 (02) : 159 - 167
  • [18] Modelling a cost-effective vaccination strategy for the prevention of varicella and herpes zoster infection: A systematic review
    Hodgkinson, Brent
    Wang, Tianjiao
    Byrnes, Joshua
    Scuffham, Paul
    VACCINE, 2021, 39 (09) : 1370 - 1382
  • [19] Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan
    Hoshi, Shu-ling
    Kondo, Masahide
    Okubo, Ichiro
    VACCINE, 2017, 35 (24) : 3264 - 3271
  • [20] Modelling the impact and cost effectiveness of universal varicella vaccination in England
    Adams, L.
    Prasinou, A. Karachaliou
    Trotter, C.
    VACCINE, 2025, 50
12345